Time-dependent p53 inhibition determines senescence attenuation and long-term outcome after renal...

Area of Science:

• Nephrology
• Molecular Biology
• Translational Medicine

Background:

• Kidney ischemia-reperfusion (I/R) injury is a significant clinical challenge, particularly in renal transplantation.
• p53 inhibition is a promising therapeutic strategy, primarily targeting apoptosis.
• p53 also regulates cellular senescence, a key factor in long-term kidney outcomes.

Purpose of the Study:

• To investigate the effect of p53 siRNA on I/R-induced cellular senescence and kidney outcomes.
• To determine the optimal duration of p53 siRNA treatment for ameliorating kidney I/R injury.

Main Methods:

• A mouse model of renal I/R was utilized.
• Mice received repetitive p53 siRNA administration over different durations (14 days vs. 26 days post-I/R).
• Senescence load and postischemic kidney phenotype were assessed.

Main Results:

• Repetitive p53 siRNA administration within the first 14 days post-I/R reduced senescence and improved kidney outcomes.
• Prolonged p53 siRNA treatment (26 days) did not enhance senescence reduction and reversed some renoprotective effects.
• These findings highlight a time-dependent role for p53 in kidney I/R injury.

Conclusions:

• Short-term p53 siRNA inhibition is beneficial for reducing I/R-induced senescence and improving kidney outcomes.
• Prolonged p53 inhibition is not advantageous and may be detrimental, supporting a limited therapeutic window.
• These results advocate for a time-dependent therapeutic strategy for p53 inhibition in kidney I/R injury.